Tacrolimus and Bleeding into the skin - a phase IV clinical study of FDA data

Summary:

Bleeding into the skin is reported as a side effect among people who take Tacrolimus (tacrolimus), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Acetaminophen, and have Thrombocytopenia.

The phase IV clinical study analyzes which people have Bleeding into the skin when taking Tacrolimus. It is created by eHealthMe based on reports of 115,828 people who have side effects when taking Tacrolimus from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Bleeding into the skin?

Bleeding into the skin is found to be associated with 939 drugs and 1,908 conditions by eHealthMe. Check the latest studies of Bleeding into the skin.

On Jul, 03, 2026

115,828 people reported to have side effects when taking Tacrolimus.
Among them, 34 people (0.03%) have Bleeding into the skin.

Could Tacrolimus cause Bleeding into the skin?

Among these 34 people:

How long have people been on Tacrolimus when they have Bleeding into the skin? *

What is the gender of people who have Bleeding into the skin when taking Tacrolimus? *

female: 53.57 %
male: 46.43 %

What is the age of people who have Bleeding into the skin when taking Tacrolimus? *

What are other drugs people take besides Tacrolimus? *

Acetaminophen: 7 people, 20.59%
Triamcinolone: 5 people, 14.71%
Sirolimus: 5 people, 14.71%
Mycophenolate Mofetil: 5 people, 14.71%
Nplate: 5 people, 14.71%
Ondansetron Hydrochloride: 4 people, 11.76%
Acyclovir: 4 people, 11.76%
Azithromycin: 4 people, 11.76%
Bactrim: 4 people, 11.76%
Cyclophosphamide: 4 people, 11.76%

What are other side effects people have besides Bleeding into the skin? *

Nausea (feeling of having an urge to vomit): 10 people, 29.41%
Diarrhea: 8 people, 23.53%
Nausea And Vomiting: 8 people, 23.53%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 7 people, 20.59%
Pain: 7 people, 20.59%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 17.65%
Anaemia (lack of blood): 6 people, 17.65%
Thrombocytopenia (decrease of platelets in blood): 6 people, 17.65%
Rashes (redness): 6 people, 17.65%
Weakness: 6 people, 17.65%

What are the existing conditions these people have? *

Bone Marrow Conditioning Regimen: 4 people, 11.76%
Thrombocytopenia (decrease of platelets in blood): 4 people, 11.76%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 3 people, 8.82%
Multiple Myeloma (cancer of the plasma cells): 3 people, 8.82%
Interstitial Lung Disease: 3 people, 8.82%
Engraftment Syndrome (inflammatory condition during neutrophil recovery after hematopoietic stem cell transplantation): 2 people, 5.88%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 5.88%
High Blood Pressure: 2 people, 5.88%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 2.94%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and have Bleeding into the skin?

- Check whether Bleeding into the skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tacrolimus:

Tacrolimus (116,160 reports)

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding into the skin:

Bleeding into the skin (939 drugs)

Browse all the conditions that are associated with Bleeding into the skin:

Bleeding into the skin (1,908 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Tacrolimus) and Tacrolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.